Description

Bacteriostatic Water for Injection – Hospira, Inc. (Pfizer Group)

Bacteriostatic Water for Injection, manufactured by Hospira, Inc., a Pfizer company, is a sterile, non-pyrogenic solution containing 0.9% benzyl alcohol as a bacteriostatic preservative. It is intended exclusively for parenteral use after adding drugs that require dilution or dissolution in an aqueous vehicle prior to injection. The solution is supplied in multi-dose vials, allowing repeated withdrawals to dilute or dissolve medications for injection.

Important Considerations

• Not for Use in Neonates: Due to the potential toxicity of benzyl alcohol in newborns, this product must not be used in this population.

• Storage: Store at controlled room temperature, between 20°C and 25°C.

• Usage: Designed exclusively for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection, according to the manufacturer’s instructions for the drug being administered.

2019 Voluntary Recall

In 2019, Hospira issued a voluntary recall for a specific lot of Bacteriostatic Water for Injection, 30 mL multi-dose vials (Lot W20308) due to potential sterility assurance concerns. This recall applied only to that lot, and no adverse events were reported.

For detailed prescribing information and usage guidelines, please refer to the official product documentation provided by Hospira.